Ophthotech DRC Phase 2 OPH2007 - A Phase 2A Open-Label Trial to ASSESS the Safety of Zimura¿ (anti-c5) Administered in Combination With Lucentis® 0.5 mg in Treatment naive subjecTs with Neovascular Age related macular degeneration
Research Grant
Administered By
Ophthalmology
Awarded By
Ophthotech Corp.
Start Date
August 6, 2018
End Date
May 28, 2019
Administered By
Ophthalmology
Awarded By
Ophthotech Corp.
Start Date
August 6, 2018
End Date
May 28, 2019